U.S. Pharmacist

Advertisement
Advertisement

Predictive Model for CKD Progression Promising

by Staff


9/20/2011

US Pharm. 2011;36(9):HS-39-HS-40. 

Researchers say they have developed and validated a tool to predict short-term risk for progression to kidney failure in patients with stage 3 to 5 chronic kidney disease (CKD). The model uses eight variables: age, sex, estimated glomerular filtration rate, albuminuria, serum calcium, serum phosphate, serum bicarbonate, and serum albumin. The primary outcome measured was kidney failure, defined as the need for dialysis or preemptive kidney transplantation. The development cohort comprised 3,449 patients (386 [11%] with kidney failure) and the validation cohort comprised 4,942 patients (1,177 [24%] with kidney failure). The research was published in JAMA.
Advertisement

U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations, long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students, other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Copyright © 2000 - 2014 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.